Term Sheet Traps: The Clauses That Cost the Most Later

The pre-money valuation is the number that appears in the press release. The clauses around it are the ones that determine, at exit, how much of the proceeds the founder and the early team actually receive. A round closed at a strong headline valuation with weak terms can produce a founder outcome that is materially worse than a round closed at a lower valuation with clean terms. The trade-off is real, and it is usually not visible to founders who have only seen one or two term sheets in their career.

The discipline is to read the term sheet in two passes. The first pass is the headline economics: pre-money, post-money, dilution. The second pass — the one that matters more — is the control and protective clauses. Most of the founder regret we see in clients who raised capital five or six years ago is not about the price they accepted; it is about the clauses they did not understand at the time.

Liquidation preference determines how the exit proceeds are divided between the preferred and the common. The market-standard term is 1x non-participating: the preferred receives the higher of (its original investment, or its pro rata share of the proceeds), and the rest goes to the common. That is the clean, founder-friendly version. Anything above 1x — 1.5x, 2x, 3x — is a multiple of the original investment that comes off the top before the common sees anything, and the math is brutal for the founders at a moderate exit.

The participating preferred variant is worse still: the preferred takes its preference and then participates in the remaining proceeds alongside the common. A 1x participating preferred at a 3x exit can leave the founder with less than half of what a 1x non-participating preferred would have produced. Investors will sometimes ask for participating preferred or higher multiples in tougher markets; founders should negotiate this clause harder than the headline valuation, because the value at stake at exit is usually larger.

Anti-dilution clauses protect investors against a down round. The market-standard term is broad-based weighted-average, which adjusts the conversion price of the preferred to reflect the dilution from the new lower-priced round, weighted by the size of the new round. The protection is real but the dilution to the founder is bounded. The hostile version is full-ratchet, which adjusts the preferred conversion price all the way down to the new round price, regardless of size, and dilutes the founder dramatically in a down round.

Full-ratchet anti-dilution was rare in the 2018–2022 period and has become more common again in the 2024–26 market. Founders should treat its presence in a term sheet as a strong signal about the investor's confidence in the next round, and should negotiate it back to broad-based weighted-average wherever possible. If the investor will not concede the clause, the term sheet should be evaluated on the assumption that the next round will trigger it.

Board composition is the operational control lever. A 2-2-1 board — two founder seats, two investor seats, one independent — sounds balanced. It is balanced only if the independent is genuinely independent. An independent selected unilaterally by the investor is, in practical terms, a third investor seat. An independent selected by mutual agreement, with a defined process for replacement, is the protection the structure was designed to provide.

The other board provision to read carefully is the matters reserved to the board versus the matters reserved to a specific share class. A board approval requirement for budget, hiring above a certain level, or material contracts is normal. A separate preferred-class approval requirement for the same matters is a veto, and stacking too many of these gives the investor effective control over operational decisions that the board structure was supposed to keep at the executive level.

Drag-along provisions allow a defined majority of shareholders to force the rest to sell on the same terms. The provision is necessary — it is what makes an exit clean rather than held up by holdout shareholders — but the threshold matters enormously. A drag-along that triggers at a majority of the preferred (or worse, a majority of a specific preferred series) puts the timing and pricing of the exit in the hands of one or two investors. A drag-along that requires a majority of the preferred and a majority of the common gives the founders a meaningful voice in the exit decision.

The drag-along interacts with liquidation preference in ways that founders rarely model in advance. A 2x participating preferred combined with a low-threshold drag-along means an investor can force a sale at a price at which the founders receive nothing, on the investor's timing rather than the founder's. The interaction is the point: read these clauses together, not separately.

Every clause you concede at Series A becomes a clause you must inherit at Series B. The new investor will benchmark the new term sheet against the previous one, and any concession the founder made earlier becomes a floor for the next negotiation. A 1.5x preference at Series A is very likely to become a 1.5x preference (or higher) at Series B. A full-ratchet anti-dilution at Series A is hard to remove without the original investor's consent, which is rarely freely given.

The implication is that the Series A term sheet matters more than its size suggests. The clauses set the trajectory of the cap table for the life of the company, and the cost of a permissive early term sheet compounds with each subsequent round. This is why we run a formal term sheet review for every fundraising client at every round, and why we are willing to extend a fundraising timeline by two or three weeks if the alternative is signing terms that will cost the founders meaningfully more at exit.

The CapMaven term sheet review is a structured walk through every clause, scored against current market benchmarks, with a written recommendation on each. The work takes two to three days from receipt of the document, and the deliverable is a single page with the headline economics, the three clauses that most warrant negotiation, and the suggested counter-position for each. The cost of the review is a small fraction of the value typically created in the renegotiation, and it converts a process the founder has done two or three times into a process the advisor has done two or three hundred times.

The right time to engage on this work is the day after the term sheet is received and the day before the founder responds. Negotiating clauses after a counter-signed term sheet is a different and harder conversation, and the leverage has largely been spent. If a term sheet is on your desk this week, the right next step is the diagnostic call.